Skip header and navigation

60 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
October 13, 2021 What is the epidemiology of variants and what are the implications for healthcare? [Evergreen] EOC031801v014 RR Table EOC
October 13, 2021 What is the epidemiology of variants and what are the implications for healthcare? EOC031801v014 RR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR Table EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 30, 2021 What is the evidence for the effectiveness of universal mask use in the pediatric population? EOC210901 RR Table EOC
September 30, 2021 What is the evidence for the effectiveness of universal mask use in the pediatric population? EOC210901 RR EOC
August 24, 2021 What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? EOC210501v2 RR EOC
August 24, 2021 What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? EOC210501v2 RR Table EOC
August 17, 2021 What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? EOC012201v3 RR EOC
August 17, 2021 What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? [Update] EOC012201v3 RR Table EOC
June 21, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 RR EOC
June 21, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 RR Table EOC
June 10, 2021 What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view? EOC210502 RR EOC
June 10, 2021 What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view? EOC210502 RR Table EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
March 15, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901 RR EOC
February 12, 2021 How effective is surveillance antigenic testing? EOC012601 RR EOC
February 4, 2021 Are there validated clinical prediction tools of which Covid-19 inpatients are most probable to require ICU level care? EOC012001 RR EOC

60 records – page 1 of 3.